CRISPR Therapeutics AGCRSPNASDAQ
Loading
Total Assets Over TimeStrong
Percentile Rank91
3Y CAGR+0.3%
5Y CAGR+4.4%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+0.3%/yr
vs +46.3%/yr prior
5Y CAGR
+4.4%/yr
Recent deceleration
Acceleration
-46.0pp
Decelerating
Percentile
P91
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$2.27B+1.0%
2024$2.24B+0.6%
2023$2.23B-0.6%
2022$2.24B-18.5%
2021$2.75B+50.5%
2020$1.83B+71.4%
2019$1.07B+118.1%
2018$489.02M+80.2%
2017$271.35M-21.3%
2016$344.96M-